Bruno Garibaldi
Catania, 95123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Journal: Blood cancer journal
Published: December 04, 2025
Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology.
Journal: Annals of hematology
Published: November 12, 2025
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Journal: Blood cancer journal
Published: July 29, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 22, 2025
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor.
Journal: Bone marrow transplantation
Published: August 24, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Journal: Annals of hematology
Published: February 25, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study.
Journal: Annals of hematology
Published: November 27, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2023
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
Journal: Cancers
Published: June 21, 2023
Last Updated: 09/26/2026